Ultraprecision therapy for type 1 vs type 2 CALR+ MPN by dual epitope targeting that restores ruxolitinib sensitivity

Journal:

Blood

Published:

2026-04-02

DOI:

10.1182/blood.2024027897

Affiliations:

10

Authors:

24

Go to article

Institutions	Authors	Share
The University of Adelaide (Adelaide Uni), Australia	10.033333 10.033333	0.42
South Australian Health and Medical Research Institute (SAHMRI), Australia	5.866667	0.24
SA Pathology, Australia	4.166667	0.17
Medical University of Graz (Med Uni Graz), Austria	2.000000	0.08
Flinders University, Australia	0.566667	0.02
Peter MacCallum Cancer Centre (Peter Mac), Australia	0.500000	0.02
The University of Melbourne (UniMelb), Australia	0.500000	0.02
Flinders Medical Center (FMC), Australia	0.366667	0.02

Interested in Cardiovascular Medicine and Haematology?